Quantcast

Posts related to ‘Sickle Cell’

Biotech Implosion: ICAgen (ICGN)

ICAgen's (ICGN-NASDAQ) stock is being crushed in after-hours trading, although the trading volume is very light.  Shares are down 37% to $1.15 after closing down 2.6% today.  Read on, because ...
Read Full Story »